Hobart Group Holdings

Hobart Group Holdings, a key player in Pharmaceutical Manufacturing, is dedicated to driving commercial excellence within the pharmaceutical and life sciences sectors. With a focus on integrated market access and outcomes, Hobart Group Holdings provides comprehensive solutions designed to meet the evolving needs of its clients. The company's commitment to innovation and strategic growth positions it as a trusted partner in the industry.

Located at Primary: 240 Main Street, Gladstone, NJ 07934, US, and with additional offices at 161 North Clark, Suite 4700, Chicago, IL 60601, US; 9 East 37th Street, 8th Floor, New York, NY 10016, US; 50 E. 91st Street, Suite 210, Indianapolis, IN 46240, US; and Four Landmark Square, Penthouse, Stamford, CT 06901, US, Hobart Group Holdings is strategically positioned to serve a wide range of clients. The company’s expertise spans across health economics, outcomes research, advanced payer analytics, and promotional effectiveness support, ensuring comprehensive and impactful results.

Hobart Group Holdings is committed to delivering exceptional value and fostering long-term partnerships. By leveraging its deep industry knowledge and innovative approaches, Hobart Group Holdings continues to enhance market access and improve patient outcomes. We invite the manager of Hobart Group Holdings to create a customized and exclusive company showcase and product listing on our platform to further highlight their unique capabilities and drive continued success.